Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|4|423-431

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.4, 2015-04, pp. : 423-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation

By  

HEPATOLOGY, Vol. 31, Iss. 6, 2000-06 ,pp. : 1345-1350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and pathological analyses of chronic vascular rejection after kidney transplantation

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 20-25

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 9, 2015-09 ,pp. : 1055-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1485-1494

John Wiley & Sons Inc

Access to resources Recommend Favorite

Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

By  

HEPATOLOGY RESEARCH, Vol. 46, Iss. 11, 2016-10 ,pp. : 1118-1128

John Wiley & Sons Inc

Access to resources Recommend Favorite